the issue is, is it the pharmaceutical manufacturers? Is it the pharmacy benefit manufacturers?
I have heard many in your industry say because they would prefer products with high list prices, because they gather fee...
the ability to afford the insulin is equally important as to the innovation that may have occurred
U.S. policy fell short of the challenge.
Hope is not a foreign policy strategy.
the net price of insulin has actually decreased, even as the list price has increased
the goal of today's hearing is to find answers and to find solutions